NCT02893137View on ClinicalTrials.gov

Enhancing Optune Therapy With Targeted Craniectomy

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 1, 2016

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Glioblastoma
Interventions
DEVICE

Optune

For further information see www.optune.com

PROCEDURE

Craniectomy

A small hole is placed in the skull between the tumor and the closest Optune electrode. The position and geometry of the craniotomy is determined by computersimulation of the electric field induced by Optune therapy. Craniotomy is a surgical procedure, which is carried out under general anaesthesia.

Trial Locations (1)

8000

Aarhus University Hospital, Aarhus C

All Listed Sponsors
collaborator

NovoCure Ltd.

INDUSTRY

lead

Aarhus University Hospital

OTHER

NCT02893137 - Enhancing Optune Therapy With Targeted Craniectomy | Biotech Hunter | Biotech Hunter